NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,559,115 | +36.4% | 1,417,502 | +50.4% | 0.08% | +44.6% |
| Q2 2023 | $45,870,906 | +45.9% | 942,682 | +66.5% | 0.06% | +40.0% |
| Q1 2023 | $31,430,036 | +1915.1% | 566,103 | +1358.0% | 0.04% | +1900.0% |
| Q4 2022 | $1,559,720 | -45.5% | 38,828 | -40.5% | 0.00% | -50.0% |
| Q3 2022 | $2,861,752 | +74.1% | 65,307 | +40.8% | 0.00% | 0.0% |
| Q2 2022 | $1,644,000 | -15.1% | 46,382 | -2.5% | 0.00% | 0.0% |
| Q1 2022 | $1,936,000 | -53.6% | 47,594 | +6.5% | 0.00% | -50.0% |
| Q4 2021 | $4,173,000 | -83.2% | 44,681 | -79.9% | 0.01% | -84.0% |
| Q3 2021 | $24,786,000 | -9.4% | 222,413 | -7.7% | 0.05% | -5.7% |
| Q2 2021 | $27,343,000 | +17.9% | 240,842 | +5.4% | 0.05% | +12.8% |
| Q1 2021 | $23,195,000 | +596.8% | 228,433 | +582.8% | 0.05% | +571.4% |
| Q4 2020 | $3,329,000 | +67.0% | 33,454 | +21.2% | 0.01% | +75.0% |
| Q3 2020 | $1,994,000 | +40.6% | 27,607 | -2.9% | 0.00% | +33.3% |
| Q2 2020 | $1,418,000 | +23.5% | 28,440 | -26.0% | 0.00% | 0.0% |
| Q1 2020 | $1,148,000 | -17.1% | 38,439 | -6.4% | 0.00% | 0.0% |
| Q4 2019 | $1,384,000 | +92.5% | 41,087 | +87.5% | 0.00% | +50.0% |
| Q3 2019 | $719,000 | +19.0% | 21,918 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $604,000 | +117.3% | 21,918 | +62.4% | 0.00% | 0.0% |
| Q1 2019 | $278,000 | +39.0% | 13,499 | -6.0% | 0.00% | – |
| Q4 2018 | $200,000 | -35.5% | 14,358 | +11.0% | 0.00% | -100.0% |
| Q3 2018 | $310,000 | +27.6% | 12,936 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $243,000 | +78.7% | 12,936 | -11.8% | 0.00% | – |
| Q1 2018 | $136,000 | +3.0% | 14,663 | 0.0% | 0.00% | – |
| Q4 2017 | $132,000 | -30.2% | 14,663 | 0.0% | 0.00% | – |
| Q3 2017 | $189,000 | +18.9% | 14,663 | 0.0% | 0.00% | – |
| Q2 2017 | $159,000 | +44.5% | 14,663 | +17.8% | 0.00% | – |
| Q1 2017 | $110,000 | -24.7% | 12,451 | 0.0% | 0.00% | – |
| Q4 2016 | $146,000 | +5.8% | 12,451 | 0.0% | 0.00% | – |
| Q3 2016 | $138,000 | -8.0% | 12,451 | 0.0% | 0.00% | – |
| Q2 2016 | $150,000 | – | 12,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |